UPDATE 1-Novartis, GBT sickle cell drugs too expensive, draft U.S. report says
January 24, 2020 at 12:02 PM EST
* Report may change after public comments (Adds share prices for Novartis, GBT in 8th paragraph)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|